Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal microbiota determines development of non-alcoholic fatty liver disease in mice
Tiphaine Le Roy, Marta Llopis, Patricia Lepage, et al.
Gut (2012) Vol. 62, Iss. 12, pp. 1787-1794
Open Access | Times Cited: 873

Showing 1-25 of 873 citing articles:

Gut microbiota in human metabolic health and disease
Yong Fan, Oluf Pedersen
Nature Reviews Microbiology (2020) Vol. 19, Iss. 1, pp. 55-71
Open Access | Times Cited: 3166
The gut microbiota and host health: a new clinical frontier
Julian R. Marchesi, David H. Adams, Francesca Fava, et al.
Gut (2015) Vol. 65, Iss. 2, pp. 330-339
Open Access | Times Cited: 2011
Gut microbiota dysbiosis contributes to the development of hypertension
Jing Li, Fangqing Zhao, Yidan Wang, et al.
Microbiome (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 1367
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota
Jérôme Boursier, Olaf Mueller, Matthieu Barret, et al.
Hepatology (2015) Vol. 63, Iss. 3, pp. 764-775
Open Access | Times Cited: 1230
From NASH to HCC: current concepts and future challenges
Quentin M. Anstee, Helen L. Reeves, Elena Kotsiliti, et al.
Nature Reviews Gastroenterology & Hepatology (2019) Vol. 16, Iss. 7, pp. 411-428
Closed Access | Times Cited: 1139
The gut–liver axis and the intersection with the microbiome
Anupriya Tripathi, Justine W. Debelius, David A. Brenner, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 7, pp. 397-411
Open Access | Times Cited: 1107
Gut microbial metabolites in obesity, NAFLD and T2DM
Emanuel E. Canfora, Ruth C. R. Meex, Koen Venema, et al.
Nature Reviews Endocrinology (2019) Vol. 15, Iss. 5, pp. 261-273
Open Access | Times Cited: 1101
Gut microbiota-derived metabolites as central regulators in metabolic disorders
Allison Agus, Karine Clément, Harry Sokol
Gut (2020) Vol. 70, Iss. 6, pp. 1174-1182
Open Access | Times Cited: 843
Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice
Jingjing Wang, Huang Tang, Chenhong Zhang, et al.
The ISME Journal (2014) Vol. 9, Iss. 1, pp. 1-15
Open Access | Times Cited: 782
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
Judith Aron‐Wisnewsky, Chloé Vigliotti, Julia J. Witjes, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 5, pp. 279-297
Open Access | Times Cited: 769
Role of intestinal microbiota and metabolites on gut homeostasis and human diseases
Lan Lin, Jianqiong Zhang
BMC Immunology (2017) Vol. 18, Iss. 1
Open Access | Times Cited: 633
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang, Cen Xie, Fei Li, et al.
Journal of Clinical Investigation (2014) Vol. 125, Iss. 1, pp. 386-402
Open Access | Times Cited: 597
Dietary metabolism, the gut microbiome, and heart failure
W.H. Wilson Tang, Daniel Y. Li, Stanley L. Hazen
Nature Reviews Cardiology (2018) Vol. 16, Iss. 3, pp. 137-154
Open Access | Times Cited: 587
Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women
Lesley Hoyles, José Manuel Fernández‐Real, Massimo Federici, et al.
Nature Medicine (2018) Vol. 24, Iss. 7, pp. 1070-1080
Open Access | Times Cited: 586
Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease
Weiwei Jiang, Na Wu, Xuemei Wang, et al.
Scientific Reports (2015) Vol. 5, Iss. 1
Open Access | Times Cited: 562
The gut microbiota: a major player in the toxicity of environmental pollutants?
Sandrine P. Claus, Hervé Guillou, Sandrine Ellero‐Simatos
npj Biofilms and Microbiomes (2016) Vol. 2, Iss. 1
Open Access | Times Cited: 561
Gut Microbiota-Derived Tryptophan Metabolites Modulate Inflammatory Response in Hepatocytes and Macrophages
Smitha Krishnan, Yufang Ding, Nima Saedi, et al.
Cell Reports (2018) Vol. 23, Iss. 4, pp. 1099-1111
Open Access | Times Cited: 515
Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease
Marta Llopis, Anne‐Marie Cassard, Laura Wrzosek, et al.
Gut (2015) Vol. 65, Iss. 5, pp. 830-839
Closed Access | Times Cited: 496
Interactions between Gut Microbiota, Host Genetics and Diet Modulate the Predisposition to Obesity and Metabolic Syndrome
Siegfried Ussar, Nicholas W. Griffin, Olivier Bézy, et al.
Cell Metabolism (2015) Vol. 22, Iss. 3, pp. 516-530
Open Access | Times Cited: 488
Gut microbiota and metabolic syndrome
Davide Festi, Ramona Schiumerini, Leonardo Henry Eusebi, et al.
World Journal of Gastroenterology (2014) Vol. 20, Iss. 43, pp. 16079-16079
Open Access | Times Cited: 483
Molecular pathways of nonalcoholic fatty liver disease development and progression
Fernando Bessone, María Valeria Razori, Marcelo G. Roma
Cellular and Molecular Life Sciences (2018) Vol. 76, Iss. 1, pp. 99-128
Closed Access | Times Cited: 468
Mouse models for human intestinal microbiota research: a critical evaluation
Floor Hugenholtz, Willem M. de Vos
Cellular and Molecular Life Sciences (2017) Vol. 75, Iss. 1, pp. 149-160
Open Access | Times Cited: 459
Gut microbiota and obesity
Philippe Gérard
Cellular and Molecular Life Sciences (2015) Vol. 73, Iss. 1, pp. 147-162
Closed Access | Times Cited: 451
The role of the microbiome in NAFLD and NASH
Aleksandra A. Kolodziejczyk, Danping Zheng, Oren Shibolet, et al.
EMBO Molecular Medicine (2018) Vol. 11, Iss. 2
Open Access | Times Cited: 443
Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation
David Porras, Esther Nistal, Susana Martínez‐Flórez, et al.
Free Radical Biology and Medicine (2016) Vol. 102, pp. 188-202
Closed Access | Times Cited: 434
Page 1 - Next Page

Scroll to top